Search
for
Sort by
Research 30 of 464
- Prophylaxis and Management of Skin Toxicities
- Skin toxicity of anti‐cancer therapy
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Cutaneous Reactions to Drugs
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Acneiform Dermatoses
- Drug-Induced Skin, Nail and Hair Disorders
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Cutaneous drug reactions
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Adverse Cutaneous Reactions to Antipsychotics
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Psychoactive drugs and skin
- Index
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Adverse cutaneous effects of psychotropic medications
- Drug eruptions in dermatology
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Update on the dermatologic use of systemic glucocorticosteroids
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology